Novartis Prevails In Cancer Patient's Zometa Injury Suit

Law360, New York (September 19, 2012, 9:00 PM EDT) -- A Texas federal judge on Tuesday ruled against a cancer patient who sued Novartis Pharmaceuticals Corp. over a jaw injury she allegedly sustained after taking Zometa, handing Novartis the latest of several wins in multidistrict litigation over the bone drug in the past several months.

U.S. District Judge Ron Clark awarded Novartis summary judgment on Beulah Conklin’s claims, part of the ongoing multidistrict litigation over bone drugs Zometa and Aredia, saying the expert opinions she provided offered no support for her allegations she had developed osteonecrosis...
To view the full article, register now.